Funding for this research was provided by:
Cancer Research UK
Experimental Cancer Medicine Centre
Article History
Received: 10 July 2024
Accepted: 16 August 2025
First Online: 11 November 2025
Declarations
:
: The study was approved by the London Bridge Research Ethics Committee on 05/09/2022 (reference: 22/PR/1199).
: Informed consent was obtained from all individual participants included in the study. No identifiable information was collected from the participants.
: The authors declare that they have no competing interests.